Medication prescribed as initial treatment and average time in weeks from diagnosis until start in patients in whom MTX, leflunomide, sulfasalazine or injectable gold was NOT started as first DMARD
| Patients (n total=78) (N, %) | Average time to start per therapy (median, IQR) | |
|---|---|---|
| Hydroxychloroquine (±NSAID) | 12 (15) | 0 (0–0) |
| Parental corticosteroid (±HCQ) | 28 (36) | 0 (0–0) |
| Oral corticosteroid (±HCQ) | 28 (36) | 0 (0–3) |
| NSAID/analgetics | 3 (4) | 0 (0–0) |
| Ciclosporin | 1 (1) | 0 (0–0) |
| Biological DMARD | 6 (8) | 64 (4–245) |
DMARD, disease-modifying antirheumatic drug; HCQ, hydroxychloroquine; NSAID, non-steroidal anti-inflammatory drug.